Pharmaceutical company AstraZeneca announced that its vaccine against COVID-19 will be withdrawn from the market. According to the company, the decision was commercial in nature, as the vaccine has not generated revenue for the organization since April 2023.
Call from to Vaxzevria, the vaccine was made in partnership with the University of Oxford and was one of the first vaccines against coronavirus, developed in a record time of 10 months. According to Astrazeneca, more than 6.5 million lives were saved in the first year of distribution alone.
“Our efforts have been recognized by governments around the world and are widely considered to be a critical component in ending the global pandemic,” the pharmaceutical company said in a press release.
Understand the reasons that led to the withdrawal of the vaccine from the market.
Find out more: COVID 2024: symptoms, necessary isolation days and tests
According to the company, the emergence of new variants of the virus caused market demand to return to other immunizers, causing a drop in demand for doses of Astrazeneca.
During its distribution, the vaccine was the subject of controversy due to the side effects of the application. In the United Kingdom, several families sued the pharmaceutical company after 51 cases of death or serious injuries caused by Thrombosis Syndrome with Thrombocytopenia. Legally, the company admitted that the vaccine can cause complications, although rare.
Vaccination is the safest and most effective way of protecting against COVID-19, as explained by Adriana Ribeiro, medical director at Pfizer Brasil, in a previous interview with MinhaVida. “Immunization remains the main form of prevention against serious cases of COVID-19, helping to reduce the risk of death and the number of hospitalizations.”
Find out more: Doctors clarify risks of the rotavirus vaccine
According to Anvisa (National Health Surveillance Agency), the vaccines against the virus currently available free of charge in the SUS (Unified Health System) are:
-
Comirnaty (Pfizer/Wyeth)
-
Bivalent Comirnaty BA.4/BA.5 (Pfizer)
-
Janssen Vaccine (Janssen-Cilag)
-
Bivalent Spikevax (Adium)
-
Spikevax (Adium)
-
Covid-19 vaccine (recombinant) (Zalika)
